Lidocaine is a common local anesthetic drug that is frequently used to numb small areas of skin or mucous membranes. It works by blocking sodium channels in nerve cell membranes, thereby stabilizing the neuronal membrane and preventing the generation and conduction of nerve impulses associated with pain. Lidocaine was first synthesized in 1943 and has become one of the most commonly used local anesthetics worldwide.
Uses of Lignocaine Ointment
Lignocaine Ointment, also known by its brand names Xylocaine and LMX, is a prescription topical medication used to provide temporary relief from pain associated with minor burns, sunburn, skin irritations, shingles, post-herpetic neuralgia, and other superficial skin disorders. Lignocaine Ointment numbs nerve endings just below the skin to reduce pain. It comes as a cream, gel, or ointment that is applied to the affected area as needed for pain relief, usually up to 3-4 times daily. Lignocaine Ointment 5% is preferred for treating skin inflammation and pain.
Benefits of Lidocaine Ointment
Some key benefits of lignocaine Ointment include:
- Provides fast-acting, temporary pain relief. Lidocaine starts working within 15-30 minutes of application and lasts for 2-4 hours.
- Non-addictive. Unlike oral pain medicines, lignocaine Ointment is a topical medication and does not carry the risk of addiction.
- Convenient to use. Lignocaine Ointment is easy to apply and does not require prescription for some strengths.
- Widely available. It can be purchased over-the-counter without a prescription in 2.5% strength. Higher 5% strength needs prescription.
- Safe for short-term use. When used as directed for a few weeks under medical guidance, lignocaine Ointment is well-tolerated and safe for most adults and children over 2 months of age.
Sales and Market Opportunity
According to industry analysts, the global lidocaine industry size was valued at USD 728.5 million in 2019 and is expected to expand at a compound annual growth rate (CAGR) of 5.5% from 2020 to 2027. The market growth can be attributed to growing geriatric population suffering from joint pain and arthritis, rising sports and traumatic injuries, surge in post-herpetic neuralgia cases due to increased varicella-zoster virus, and increasing preference for topical pain medications over oral drugs due to minimal systemic side effects.
North America currently dominates the lidocaine market with the highest revenue share of over 35% in 2019. However, the Asia Pacific region is likely to foster highest growth during the forecast period owing to improving access to healthcare, increasing medical tourism, rising disposable incomes and healthcare spending in developing countries like India and China. The demand for lidocaine is also rising in Europe and Latin America fueled by growing awareness about topical analgesics.
Competition in Lidocaine Ointment
Some of the prominent companies marketing lignocaine Ointment and other formulations globally include AstraZeneca Plc., Septodont Healthcare India Pvt. Ltd., Dentsply Sirona, Patterson Dental, 3M, Pfizer Inc., Glenmark Pharmaceuticals, Teligent, Endo Pharmaceuticals Inc., and Amneal Pharmaceuticals LLC. The lidocaine market is highly competitive with these players differentiating their offerings through product innovation, expansion to emerging nations, mergers & acquisitions, and promotional campaigns to reinforce brand positioning.
Going forward, market leaders are focusing on new lidocaine product launches including pain-relieving patches and gels to expand consumer base. Companies are also trying to develop lidocaine formulations with enhanced absorption properties and extended duration of action through novel drug delivery technologies. Though dominated by multinational pharma majors, local lidocaine manufacturers have been steadily increasing their market share in price-sensitive developing nations.
Concluding Remarks
In summary, Lidocaine Ointment is an inexpensive and effective over-the-counter topical treatment used by millions worldwide for temporary relief from various painful skin conditions. The lidocaine market provides lucrative opportunities owing to growing target patient base, increasing preference for topical analgesics, and new product innovations. Market players stand to benefit by expanding access to underpenetrated markets and diversifying their pain relief portfolios. Lidocaine is poised to retain its importance as one of the most commonly employed local anesthetics.
Priya Pandey is a dynamic and passionate editor with over three years of expertise in content editing and proofreading. Holding a bachelor's degree in biotechnology, Priya has a knack for making the content engaging. Her diverse portfolio includes editing documents across different industries, including food and beverages, information and technology, healthcare, chemical and materials, etc. Priya's meticulous attention to detail and commitment to excellence make her an invaluable asset in the world of content creation and refinement.
(LinkedIn- https://www.linkedin.com/in/priya-pandey-8417a8173/
